PARIS, April 29, 2016 /PRNewswire/ -- Sanofi, a global
and diversified healthcare leader, reports results for the first
quarter of 2016. Jérôme Contamine, Chief Financial Officer of
Sanofi, comments on the Group's Q1 results and guidance for the
rest of the year.
Watch video interview and read transcript:
http://eurobusinessmedia.com/ceo-direct/sanofi/q1-2016-results-interview-with-cfo-jerome-contamine?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
- Q1 highlights
- Specialty Care
- Dengvaxia®
- Diabetes
- Consumer Healthcare
- Venezuela
- Outlook
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs.
Sanofi is organized into five global business units: Diabetes and
Cardiovascular, General Medicines and Emerging Markets, Sanofi
Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in
Paris (EURONEXT: SAN) and in
New York (NYSE: SNY).